|
- Sumi Biswas — Nuffield Department of Medicine
Sumi Biswas Associate Professor My research interests include development of vaccines against malaria and primarily vaccines that aim to block the sexual development of the malaria parasite in the mosquito vector and block transmission
- Sumi Biswas - SpyBiotech
Sumi Biswas is a highly qualified immunologist with a compelling vision to apply SpyBiotech’s protein superglue technology to commercial vaccine development and production She leads both scientific and strategic business development for the company Sumi combines a deep understanding of the relevant science with an interest in business and a talent for mobilizing teams around an inspiring purpose – qualities that were instrumental in securing initial investment for SpyBiotech In 2017
- Sumi Biswas - Google Scholar
University of Oxford - Cited by 3,593 - Vaccinology - infectious disease
- Sumi Biswas WBCS given addl charge as Assistant Director (HQ . . .
Ms Sumi Biswas WBCS (Exe) presently Dy Director of Survey, Indo-Bangladesh Boundary Demarcation, has been appointed given additional charge as Assistant Director (HQ), Directorate of Land Records Surveys
- Dr Sumi BiswasCo-Investigator | VaxHub Sustainable
Dr Sumi Biswas Co-Investigator Sumi Biswas is an Associate Professor of Vaccinology at the Jenner Institute, University of Oxford, where she leads the Transmission Blocking Malaria Vaccine Group She is also a co-founder, President, and Chief Scientific Officer of SpyBiotech Limited, a biotech company working on developing effective vaccines
- Meet Prof Sumi Biswas, co-founder of SpyBiotech, that helps COVID . . .
Professor Sumi Biswas, Chief Executive Officer (CEO) and co-founder of SpyBiotech, an Oxford University spinoff company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases, recently announced that its Indian partner, the Serum Institute of India (SIIPL), has begun trials of a novel virus-like particle (VLP
- Sumi Biswas — The Jenner Institute
Sumi Biswas Associate Professor My research interests include development of vaccines against malaria and primarily vaccines that aim to block the sexual development of the malaria parasite in the mosquito vector and block transmission
- Sumi Biswas - President, Co-Founder Chief Scientific Officer at . . .
About Sumi is a highly qualified immunologist with a compelling vision to apply the company's protein superglue technology to commercial vaccines development and production She leads on both the scientific and strategic business development of the company Sumi combines a deep understanding of the relevant science with an interest in business and a talent for mobilising teams around an inspiring purpose - qualities that were instrumental in securing initial investment for SpyBiotech In
|
|
|